Saudi Chemical Co. - stock earnings
2230.SR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 89.0 million SAR | 1.4 billion SAR |
| 2023Q3 | 35.1 million SAR | 1.2 billion SAR |
| 2023Q2 | 26.5 million SAR | 1.2 billion SAR |
| 2023Q1 | 32.3 million SAR | 1.0 billion SAR |
| 2022Q4 | 23.4 million SAR | 1.1 billion SAR |
| 2022Q3 | 10.3 million SAR | 760.5 million SAR |
| 2022Q2 | 13.8 million SAR | 956.7 million SAR |
| 2022Q1 | 32.7 million SAR | 904.0 million SAR |
| 2021Q4 | -6.3 million SAR | 756.4 million SAR |
| 2021Q3 | 7.8 million SAR | 785.3 million SAR |
| 2021Q2 | 27.3 million SAR | 899.9 million SAR |
| 2021Q1 | 40.8 million SAR | 969.5 million SAR |
| 2020Q4 | -23.0 million SAR | 836.5 million SAR |
| 2020Q3 | 18.9 million SAR | 811.4 million SAR |
| 2020Q2 | 40.2 million SAR | 858.7 million SAR |
| 2020Q1 | 28.0 million SAR | 799.6 million SAR |
| 2019Q4 | -50.7 million SAR | 588.6 million SAR |
| 2019Q3 | 13.4 million SAR | 739.8 million SAR |
| 2019Q2 | 30.9 million SAR | 778.4 million SAR |
| 2019Q1 | 39.3 million SAR | 842.4 million SAR |
| 2018Q4 | 18.2 million SAR | 872.8 million SAR |
| 2018Q3 | 13.5 million SAR | 630.8 million SAR |
| 2018Q2 | 27.8 million SAR | 653.8 million SAR |
| 2018Q1 | 555.1 million SAR | 791.2 million SAR |
| 2017Q4 | 30.7 million SAR | 699.4 million SAR |
| 2017Q3 | 28.0 million SAR | 513.2 million SAR |
| 2017Q2 | 28.5 million SAR | 544.3 million SAR |
| 2017Q1 | 55.2 million SAR | 724.7 million SAR |
| 2016Q4 | 17.4 million SAR | 491.5 million SAR |
| 2016Q3 | 20.2 million SAR | 445.0 million SAR |
| 2016Q2 | 47.7 million SAR | 618.3 million SAR |
| 2016Q1 | 52.8 million SAR | 591.3 million SAR |
| 2015Q4 | 51.6 million SAR | 607.6 million SAR |
| 2015Q3 | 25.7 million SAR | 489.7 million SAR |
| 2015Q2 | 48.1 million SAR | 636.1 million SAR |
| 2015Q1 | 86.6 million SAR | 678.5 million SAR |
| 2012Q2 | 86.9 million SAR | 464.5 million SAR |
2230.SR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 182.9 million SAR | 4.9 billion SAR |
| 2022 | 50.5 million SAR | 3.4 billion SAR |
| 2021 | 69.6 million SAR | 3.4 billion SAR |
| 2020 | 74.0 million SAR | 3.3 billion SAR |
| 2019 | 32.9 million SAR | 2.9 billion SAR |
| 2018 | 116.0 million SAR | 2.9 billion SAR |
| 2017 | 143.1 million SAR | 2.5 billion SAR |
| 2016 | 137.8 million SAR | 2.1 billion SAR |
| 2015 | 251.6 million SAR | 2.4 billion SAR |
| 2014 | 283.6 million SAR | 2.5 billion SAR |
| 2013 | 300.6 million SAR | 2.3 billion SAR |
| 2012 | 291.3 million SAR | 2.0 billion SAR |
| 2011 | 267.4 million SAR | 1.9 billion SAR |
| 2010 | 303.2 million SAR | 1.7 billion SAR |
| 2009 | 301.0 million SAR | 1.6 billion SAR |
| 2008 | 200.5 million SAR | 1.5 billion SAR |
| 2007 | 111.8 million SAR | 1.2 billion SAR |
2230.SR
Price: SAR9.03
Dividend Yield: 0.01%
Forward Dividend Yield: 0.55%
Payout Ratio: 22.73%
Dividend Per Share: 0.05 SAR
Earnings Per Share: 0.22 SAR
P/E Ratio: 32.21
Exchange: SAU
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 6.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 4